Literature DB >> 707590

Neovasculogenic ability of prostaglandins, growth factors, and synthetic chemoattractants.

D BenEzra.   

Abstract

Prostaglandins E1, E2, D2, A1, F1alpha, and F2alpha as well as synthetic chemoattractants and growth factors were tested for their ability to induce the proliferation of new blood vessels in the rabbit cornea. PGE1 showed the strongest neovasculogenic activity attracting new blood vessels in all of the cases. PGE2 was a weaker attractant than PGE1. PGF2alpha induced a less consistent reaction. All implants sequestering PGD2 or PGA1 were negative. Implants sequestering 1 microgram of fibroblast growth factor or epidermal growth factor variably stimulated the proliferation of keratocytes and epithelial cells in vivo. However, none of these demonstrated any vasculogenic activity. A small, but significant neovascularization was observed only in implants sequestering 10 microgram of growth factor per implant. Although active in vitro, nerve growth factor and formylated synthetic peptides were not stimulatory in vivo.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 707590     DOI: 10.1016/0002-9394(78)90289-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  25 in total

1.  Laser photocoagulation for corneal stromal vascularization.

Authors:  V S Nirankari
Journal:  Trans Am Ophthalmol Soc       Date:  1992

2.  Effects of prostaglandins on regional remodeling changes during tibial healing in beagles: a histomorphometric study.

Authors:  M S Shih; R W Norridin
Journal:  Calcif Tissue Int       Date:  1986-09       Impact factor: 4.333

3.  Senile macular degeneration: the involvement of immunocompetent cells.

Authors:  P L Penfold; M C Killingsworth; S H Sarks
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1985       Impact factor: 3.117

4.  Ocular neovascularization. Experimental animal model and studies on angiogenic factor(s).

Authors:  S S Hayreh; G F Lata
Journal:  Int Ophthalmol       Date:  1986-05       Impact factor: 2.031

5.  Beta-N-acetyl-glucosaminidase: possible role in ocular neovascularization.

Authors:  K M Morgan; W E Bruner; G F Lata; S S Hayreh
Journal:  Int Ophthalmol       Date:  1986-05       Impact factor: 2.031

Review 6.  A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction).

Authors:  B A Teicher
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

7.  Hypotony and experimental rubeosis iridis in primate eyes. A clinicopathologic study.

Authors:  G A Peyman; M Raichand; C P Juarez; S Reinglass; E John
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

8. 

Authors:  R Rochels
Journal:  Doc Ophthalmol       Date:  1984-05       Impact factor: 2.379

9.  The microvascular response to growth factors in the hamster cheek pouch.

Authors:  C Orlandi; A J Paskins-Hurlburt; N K Hollenberg
Journal:  Basic Res Cardiol       Date:  1986 May-Jun       Impact factor: 17.165

Review 10.  Vascular endothelial growth factor and ocular neovascularization.

Authors:  J W Miller
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.